NASDAQ:ACRS | Key Financial Ratios | Aclaris Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-303.46-42.15%-60.79%
2026-03-314.03-35.06%-48.49%
2025-12-313.36-40.46%-62.98%
2025-09-303.92-80.71%-117.97%
2025-06-303.88-71.19%-102.21%
2025-03-315.06-65.73%-90.38%
2024-12-313.99-59.94%-84.90%
2024-09-307.03-20.29%-28.43%
2024-06-307.5-36.43%-43.85%
2024-03-316.74-44.39%-54.40%
2023-12-314.16-44.82%-56.29%
2023-09-304.5-52.50%-73.32%
2023-06-305.82-44.69%-58.59%
2023-03-3110.1-41.91%-54.45%
2022-12-3110.55-34.14%-43.98%
2022-09-3012.97-30.67%-37.34%
2022-06-3015.99-29.96%-35.32%
2022-03-3111.41-35.71%-44.89%
2021-12-318.94-36.17%-46.04%
2021-09-3011.54-30.83%-37.51%
2021-06-3016.17-24.56%-30.26%
2021-03-319.27-39.77%-57.16%
2020-12-313.87-72.07%-135.50%
2020-09-304.54-78.49%-138.47%
2020-06-304-118.94%-204.79%
2020-03-314.01-143.96%-239.69%
2019-12-313.74-164.15%-230.80%
2019-09-303.73-113.03%-212.62%
2019-06-303.23-73.07%-115.67%
2019-03-314.33-55.33%-76.86%
2018-12-316.56-48.17%-61.70%
2018-09-306.53-66.48%-80.04%
2018-06-308.53-50.82%-58.88%
2018-03-3113.91-39.07%-43.00%
2017-12-3115.69-28.14%-30.42%
2017-09-3023.43-21.83%-23.36%
2017-06-3021-28.03%-29.48%
2017-03-3127.91-28.64%-29.70%
2016-12-3122.27-27.30%-28.37%
2016-09-3018.64-48.00%-50.93%
2016-06-3017.37-42.93%-45.72%
2016-03-3123.29-35.50%-37.23%
2015-12-3155.64-21.86%-22.23%
2015-09-3020.75-43.83%48.39%
2014-12-3111.26

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-313.36-40.46%-62.98%
2024-12-313.99-59.94%-84.90%
2023-12-314.16-44.82%-56.29%
2022-12-3110.55-34.14%-43.98%
2021-12-318.94-36.17%-46.04%
2020-12-313.87-72.07%-135.50%
2019-12-313.74-164.15%-230.80%
2018-12-316.56-48.17%-61.70%
2017-12-3115.69-28.14%-30.42%
2016-12-3122.27-27.30%-28.37%
2015-12-3155.64-21.86%-22.23%
2014-12-3111.26-49.01%41.04%
2013-12-3157.14%